He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.
In this video, Daniel von Allmen, MD, from Cincinnati Children's Hospital, discusses when a clinician should consider surgery over systemic therapy for the treatment of pediatric inflammatory bowel...
In this video, Cardiology Consultant Advisory Board Member Seth Baum, MD, discusses the challenges that the COVID-19 pandemic has presented and how cardiologists have been able to successfully overcome...
In this video, W. Clay Jackson, MD, DipTH, speaks about 4 specific tips to address a patient's behavioral problem and how to communicate boundaries. The suggestions range from ignoring the behavior to...
